CLINICAL
Interpretation and Reporting
With over 3 million NGS patient test cases interpreted worldwide, QIAGEN’s trusted portfolio of clinical interpretation and reporting solutions delivers the molecular insight you need to make confident decisions for every patient, every time.
Interpretation and Reporting Solutions
QCI Interpret for Oncology
Clinical decision support software for variant interpretation and reporting for somatic NGS testing
QCI Interpret for Hereditary
Clinical decision support software for variant interpretation and reporting for germline NGS testing
QCI Precision Insights
Professional clinical interpretation services that provide patient-specific clinical analysis of molecular data
Munich Leukemia Laboratory selects QCI Interpret for NGS solid tumor testing
Munich Leukemia Laboratory, one of the world’s largest leukemia laboratories, has selected QCI Interpret for Oncology to support the analysis, interpretation, and reporting of Illumina’s TruSight Oncology 500 Assay, a comprehensive genomic profiling test for solid tumors.